BTTC

MKT CAP:$10M

Black Titan Corporation

Market Cap

$10M

Financial Services·Asset Management·🇰🇾 Cayman Islands·NASDAQ

Financials·Asset Management·🇰🇾·NASDAQ

Stock Price

$1.34-$0.49 (-26.78%)

Apr 23, 2026

Company Details

Black Titan Corp. was formed for the purpose of effecting a merger between Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd. It intends to explore and identify viable business opportunities. The company was founded on July 11, 2024 and is he...

CEO

Weei Jye Chay

IPO Date

Oct 2, 2025

Website

www.blacktitancorp.com

Key Metrics TTM

Revenue

$0

-100.0% YoY

Net Income

-$1.8B

EPS (Diluted)

-$1.18

Free Cash Flow

-$329M

Revenue / Share

$0.00

Gross Margin

—

Operating Margin

—

Net Margin

—

FCF Margin

—

P/S

—

P/E

—

Earnings Reports

Q4 2025

May 15, 2026

PENDING

FY 2025

Nov 28, 2025

$3M+26.3%EPS $0.00

Q3 2025

Nov 28, 2025

$0EPS -$0.47

Q1 2025

Jun 9, 2025

$0-100.0%EPS -$0.17

FY 2024

Jul 31, 2024

$2M+2.0%EPS $0.02

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 21	$264.0K	$86.6K	-$3.0K
Q4 21	$135.0K	$82.0K	-$2M
Q1 22	$192.0K	$140.0K	-$3M
Q2 22	$150.0K	$99.0K	-$2M
Q3 22	$95.0K	$47.0K	-$3M
Q4 22	$121.0K	$76.0K	-$3M
Q1 23	$98.0K	$55.0K	-$2M
Q2 23	$83.0K	$44.0K	-$2M
Q3 23	$4.0K	-$23.0K	-$2M
Q4 23	$0	-$3.0K	-$2M
Q1 24	$454.6K	$124.8K	-$340.3K
Q2 24	$582.0K	$247.6K	$368.8K
Q3 24	$0	$0	-$754.0K
Q4 24	$0	$0	-$666.0K
Q1 25	$0	$0	-$534.0K
Q3 25	$0	$0	-$777.0K

Valuation

Quarter	P/S	P/E
Q3 21	12.1x	—
Q4 21	11.1x	—
Q1 22	16.4x	—
Q2 22	22.9x	—
Q3 22	29.7x	—
Q4 22	30.4x	—
Q1 23	36.6x	—
Q2 23	42.8x	—
Q3 23	55.5x	—
Q4 23	91.8x	—
Q1 24	31.3x	—
Q2 24	16.3x	—
Q3 24	16.4x	—
Q4 24	16.4x	—
Q1 25	29.2x	—
Q3 25	—	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 20	$40.3K	$40.3K
Q1 21	-$3M	-$3M
Q2 21	-$2M	-$2M
Q4 21	-$1M	-$1M
Q1 22	-$3M	-$3M
Q2 22	-$2M	-$2M
Q4 22	-$2M	-$2M
Q1 23	-$2M	-$2M
Q3 23	-$2M	-$2M
Q4 23	-$2M	-$2M
Q1 24	$78.8K	$77.5K
Q2 24	-$8.8K	-$9.0K
Q3 24	-$693.0K	-$693.0K
Q4 24	-$506.0K	-$506.0K
Q1 25	-$867.0K	-$867.0K
Q3 25	-$327M	-$327M

Capital Expenditures

Quarter	CapEx
Q4 20	$0
Q1 21	$0
Q2 21	$18.0K
Q4 21	$5.0K
Q1 22	$0
Q2 22	$0
Q4 22	$0
Q1 23	$0
Q3 23	$0
Q4 23	$2.0K
Q1 24	$1.3K
Q2 24	$227
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q3 25	$5.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 21	-78.3%	-94.7%
Q4 21	+763.3%	+2055.1%
Q1 22	-71.8%	-17.6%
Q2 22	-66.3%	-6.4%
Q3 22	-64.0%	+925.3%
Q4 22	-10.4%	+4.1%
Q1 23	-49.0%	-34.3%
Q2 23	-44.7%	-35.5%
Q3 23	-95.8%	-24.6%
Q4 23	-100.0%	-29.3%
Q1 24	+363.8%	-55.7%
Q2 24	+601.3%	-87.2%
Q3 24	-100.0%	-63.5%
Q4 24	—	-65.5%
Q1 25	-100.0%	-32.8%
Q3 25	-100.0%	+264.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 20	$0	0.0%
Q1 21	$0	0.0%
Q2 21	$0	0.0%
Q4 21	$0	0.0%
Q1 22	$0	0.0%
Q2 22	$0	0.0%
Q4 22	$0	0.0%
Q1 23	$0	0.0%
Q3 23	$0	0.0%
Q4 23	$0	—
Q1 24	$94.3K	20.7%
Q2 24	$0	0.0%
Q3 24	$0	—
Q4 24	$0	—
Q1 25	$0	—
Q3 25	$1.1B	—

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q3 21	$1M	$89.7K	—	—
Q4 21	$976.0K	—	—	$2M
Q1 22	$1M	—	—	$1M
Q2 22	$974.0K	—	—	$2M
Q3 22	$932.0K	—	—	$2M
Q4 22	$1M	—	—	$1M
Q1 23	$561.0K	—	—	$1M
Q2 23	$442.0K	—	—	$1M
Q3 23	$424.0K	—	—	$2M
Q4 23	$487.0K	—	—	$1M
Q1 24	—	$461.6K	$3.5K	—
Q2 24	—	—	$5.9K	—
Q3 24	—	—	—	$754.0K
Q4 24	—	—	—	$666.0K
Q1 25	—	—	—	$534.0K
Q3 25	—	$1.8B	—	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 21	$7M	$0	$7M
Q4 21	$6M	$0	$6M
Q1 22	$8M	$0	$8M
Q2 22	$7M	$0	$7M
Q3 22	$5M	$0	$5M
Q4 22	$3M	$0	$3M
Q1 23	$1M	$0	$1M
Q2 23	$122.0K	$0	$122.0K
Q3 23	$8M	$0	$8M
Q4 23	$7M	$0	$7M
Q1 24	$6.6K	$0	$6.6K
Q2 24	$684.5K	$0	$684.5K
Q3 24	$3M	$0	$3M
Q4 24	$372.0K	$0	$372.0K
Q1 25	$2M	$0	$2M
Q4 25	$575.1K	$0	$575.1K

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 21	20M	0.0%	+24581.3%
Q4 21	493K	-97.6%	—
Q1 22	536K	+8.7%	+15.5%
Q2 22	4M	+579.2%	-82.0%
Q3 22	5M	+46.7%	-73.6%
Q4 22	7M	+38.4%	+1399.5%
Q1 23	5M	-33.3%	+820.0%
Q2 23	8M	+52.1%	+106.1%
Q3 23	5M	-36.5%	-10.9%
Q4 23	5M	+0.6%	-35.2%
Q1 24	7M	+50.5%	+46.1%
Q2 24	9M	+26.8%	+21.7%
Q3 24	7M	-21.6%	+50.5%
Q4 24	5M	-28.3%	+7.4%
Q1 25	5M	-0.3%	-28.9%
Q3 25	4M	-24.8%	-57.8%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 21	—	—
Q4 21	—	—
Q1 22	—	—
Q2 22	—	—
Q3 22	—	—
Q4 22	—	—
Q1 23	—	—
Q2 23	—	—
Q3 23	—	—
Q4 23	—	—
Q1 24	—	—
Q2 24	—	—
Q3 24	—	—
Q4 24	—	—
Q1 25	—	—
Q3 25	$0	300

Revenue / Employee